Barclays’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$11K | – | 7481 |
|
|
2018
Q1 | $11K | Buy |
3,000
+1,500
| +100% | +$4.91K | ﹤0.01% | 6646 |
|
|
2017
Q4 | $4K | Sell |
1,500
-3,400
| -69% | -$12.4K | ﹤0.01% | 6716 |
|
|
2017
Q3 | $22K | Buy |
4,900
+3,600
| +277% | +$16K | ﹤0.01% | 5760 |
|
|
2017
Q2 | $6K | Buy |
1,300
+200
| +18% | +$804 | ﹤0.01% | 6212 |
|
|
2017
Q1 | $5K | Sell |
1,100
-3,200
| -74% | -$13.3K | ﹤0.01% | 6301 |
|
|
2016
Q4 | $18K | Sell |
4,300
-1,700
| -28% | -$9.04K | ﹤0.01% | 5688 |
|
|
2016
Q3 | $49K | Buy |
6,000
+3,600
| +150% | +$30.6K | ﹤0.01% | 4993 |
|
|
2016
Q2 | $19K | Sell |
2,400
-4,700
| -66% | -$40.3K | ﹤0.01% | 5301 |
|
|
2016
Q1 | $50K | Sell |
7,100
-41,000
| -85% | -$300K | ﹤0.01% | 4768 |
|
|
2015
Q4 | $481K | Buy |
48,100
+2,300
| +5% | +$20.9K | ﹤0.01% | 3256 |
|
|
2015
Q3 | $275K | Sell |
45,800
-46,400
| -50% | -$378K | ﹤0.01% | 3880 |
|
|
2015
Q2 | $738K | Sell |
92,200
-19,800
| -18% | -$187K | ﹤0.01% | 3151 |
|
|
2015
Q1 | $1.01M | Sell |
112,000
-93,300
| -45% | -$1.17M | ﹤0.01% | 2976 |
|
|
2014
Q4 | $2.46M | Buy |
205,300
+139,400
| +212% | +$1.7M | ﹤0.01% | 2334 |
|
|
2014
Q3 | $593K | Sell |
65,900
-23,100
| -26% | -$214K | ﹤0.01% | 3809 |
|
|
2014
Q2 | $623K | Buy |
89,000
+65,000
| +271% | +$259K | ﹤0.01% | 3771 |
|
|
2014
Q1 | $72K | Sell |
24,000
-84,700
| -78% | -$296K | ﹤0.01% | 5704 |
|
|
2013
Q4 | $326K | Sell |
108,700
-76,400
| -41% | -$222K | ﹤0.01% | 4518 |
|
|
2013
Q3 | $555K | Buy |
185,100
+19,400
| +12% | +$133K | ﹤0.01% | 4000 |
|
|
2013
Q2 | $1.35M | Buy |
+165,700
| New | +$1.26M | ﹤0.01% | 2989 |
|